By / December 12, 2024

Berlin Will Launch Pilot Project for Legal Cannabis Sales

The districts of Friedrichshain-Kreuzberg and Neukölln in Berlin have been granted the right to launch a pilot project aimed at studying the effects of controlled cannabis distribution for recreational use.

In collaboration with Sanity Group and Humboldt University of Berlin, this scientific initiative seeks to develop responsible cannabis policy in Germany.

Sanity Group is already overseeing a similar pilot project in Switzerland, the Grashaus Project.

For more news like this, along with all the latest in legalization, research, and lifestyle, download our free cannabis news app.

Objectives and Framework of the Berlin Project

The primary goal of the Berlin project is to examine the conditions under which cannabis can be distributed to consumers for recreational use in regulated retail outlets. According to Clara Herrmann, the mayor of the Friedrichshain-Kreuzberg district, the results will serve as the foundation for implementing a policy that ensures controlled quality products while incorporating effective prevention measures and support for addicts.

Participants residing in these Berlin districts who meet health and residency requirements will have the opportunity to legally purchase cannabis at selected retail outlets. To ensure comprehensive data collection, participants must regularly take part in scientific surveys.

It will be strictly prohibited to transfer purchased products to others, with any violation resulting in immediate exclusion from the study. A control group in Berlin, consisting of members from a local cannabis social club, will also support the research.

The five-year Berlin project includes the presence of specialized staff at retail outlets to address concerns related to consumption. These qualified professionals will monitor participants for any harmful behavior and refer them to counseling services if needed. Additionally, a prevention officer and a medical supervisor will oversee the progress of the study.

A portion of the revenue generated from cannabis sales in Berlin will be allocated to fund prevention initiatives and support services for addicts in the districts, ensuring the community directly benefits from the project’s outcomes.

Federal Government’s Involvement in Cannabis Research

At the national level, the Federal Ministry of Food and Agriculture (BMEL) has reinforced its commitment to cannabis research.

Under the newly published Cannabis Consumer Competencies Regulation, the Federal Agency for Agriculture and Food (BLE) will oversee the review and monitoring of research proposals related to recreational cannabis and industrial hemp, including the Berlin project.

This decision marks a shift from the Federal Institute for Drugs and Medical Devices (BfArM), which will now focus exclusively on research into medical cannabis.

Federal Minister Cem Özdemir emphasized the importance of research in combating the black market, improving preventive healthcare, and promoting a data-driven cannabis policy debate.

The regulation allows universities and private companies to submit proposals, provided they meet the strict criteria outlined in the recreational cannabis law. Approved projects will provide a deeper understanding of cannabis’ impact on society and health, in line with Germany’s broader legalization strategy.

Challenges Remain for Berlin

Despite the progressive intentions of these initiatives, challenges persist in Berlin. Hannes Rehfeldt, Neukölln’s district advisor for social affairs and health, expressed concerns about the cannabis consumption law, calling it poorly designed.

He criticized the lack of federal funding for prevention and addiction support, highlighting that partial legalization around Berlin could inadvertently fuel organized crime.

“It is essential that those who consume cannabis legally can access it safely and do not depend on the dangerous black market,” Rehfeldt noted about the Berlin project.

(Featured image courtesy of Xu Chen via Pexels)

DISCLAIMER: This article was written by a third-party contributor and does not reflect the opinion of Hemp.im, its management, staff, or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the company may believe that its expectations are based on reasonable assumptions, the actual results that the company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in Newsweed, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.


Comments are closed for this post.